{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:15:46Z","timestamp":1790489746756,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C1994\/A28701"],"award-info":[{"award-number":["C1994\/A28701"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"DH | National Institute for Health Research","doi-asserted-by":"publisher","award":["NIHR203308"],"award-info":[{"award-number":["NIHR203308"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Radiotherapy induces systemic changes beyond the targeted tumour site, yet the biological mechanisms driving these effects remain poorly understood. This study aims to longitudinally profile acute systemic plasma proteomic responses to radiotherapy in patients with prostate, bladder, and head and neck cancers, providing insight into shared and tumour-specific effects and identifying biomarkers predictive of treatment-related toxicities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We apply our previously developed Nano-proteomics workflow to comprehensively analyse longitudinal weekly plasma samples collected before and during radiotherapy. We perform mass spectrometry-based differential protein analysis to identify acute changes of the plasma proteome and enriched biological pathways involved. In the prostate cohort, we associate plasma proteomics with clinical toxicity outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our data indicate that the most significant systemic proteomic changes occur within the first two weeks of radiotherapy, highlighting a critical period for biomarker identification. Across all patient cohorts, we observe common biological responses: rapid activation of inflammatory and immune pathways, followed by structural reorganisation and immune resolution, regardless of tumour type or concurrent treatments. Despite this shared acute response, distinct protein mediators are found to be dysregulated in a tumour-specific manner. In the prostate cancer cohort, plasma profiling at baseline, one week after the initiation of radiotherapy, and at the end of radiotherapy, \u00a0results in the identification of\u00a028, 29, and 20 proteins, respectively, that are associated with subsequent bowel and urinary toxicities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study underscores the value of longitudinal proteomics in uncovering systemic effects of radiotherapy and supports the potential of plasma proteomic biomarkers to identify patients at increased risk of radiotherapy-induced toxicity, paving the way for personalised treatment strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s43856-026-01552-3","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:56:31Z","timestamp":1775058991000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Longitudinal plasma nano-proteomics reveals acute systemic responses to radiotherapy and predictive biomarkers of late toxicity"],"prefix":"10.1038","volume":"6","author":[{"given":"Hanan","family":"Abumanhal-Masarweh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5634-1347","authenticated-orcid":false,"given":"Salam A.","family":"Assi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8809-3907","authenticated-orcid":false,"given":"Xinming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9348-3130","authenticated-orcid":false,"given":"Conrado","family":"Guerrero Quiles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6891-0866","authenticated-orcid":false,"given":"Taha","family":"Lodhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7708-3770","authenticated-orcid":false,"given":"Kaye J.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor J.","family":"Cheadle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2224-6672","authenticated-orcid":false,"given":"Kostas","family":"Kostarelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananya","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7572-3196","authenticated-orcid":false,"given":"David C.","family":"Wedge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0839-3449","authenticated-orcid":false,"given":"Catharine M. L.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4720-2112","authenticated-orcid":false,"given":"Marilena","family":"Hadjidemetriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"1552_CR1","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1080\/09553002.2017.1304590","volume":"93","author":"K Jelonek","year":"2017","unstructured":"Jelonek, K., Pietrowska, M. & Widlak, P. Systemic effects of ionizing radiation at the proteome and metabolome levels in the blood of cancer patients treated with radiotherapy: the influence of inflammation and radiation toxicity. Int. J. Radiat. Biol. 93, 683\u2013696 (2017).","journal-title":"Int. J. Radiat. Biol."},{"key":"1552_CR2","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.3390\/cancers11091324","volume":"11","author":"K Bal\u00e1zs","year":"2019","unstructured":"Bal\u00e1zs, K. et al. Radiotherapy-induced changes in the systemic immune and inflammation parameters of head and neck cancer patients. Cancers 11, 1324 (2019).","journal-title":"Cancers"},{"key":"1552_CR3","doi-asserted-by":"publisher","first-page":"62742","DOI":"10.18632\/oncotarget.18409","volume":"8","author":"HHW Chen","year":"2017","unstructured":"Chen, H. H. W. & Kuo, M. T. Improving radiotherapy in cancer treatment: promises and challenges. Oncotarget 8, 62742\u201362758 (2017).","journal-title":"Oncotarget"},{"key":"1552_CR4","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41571-022-00697-z","volume":"19","author":"M-C Vozenin","year":"2022","unstructured":"Vozenin, M.-C., Bourhis, J. & Durante, M. Towards clinical translation of FLASH radiotherapy. Nat. Rev. Clin. Oncol. 19, 791\u2013803 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1552_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BSR20182319","volume":"39","author":"A Ouerhani","year":"2019","unstructured":"Ouerhani, A., Chiappetta, G., Souiai, O., Mahjoubi, H. & Vinh, J. Investigation of serum proteome homeostasis during radiation therapy by a quantitative proteomics approach. Biosci. Rep. 39, 1\u201313 (2019).","journal-title":"Biosci. Rep."},{"key":"1552_CR6","doi-asserted-by":"publisher","first-page":"e557s","DOI":"10.6061\/clinics\/2018\/e557s","volume":"73","author":"H Carvalho","year":"2018","unstructured":"Carvalho, H., de, A. & Villar, R. C. Radiotherapy and immune response: the systemic effects of a local treatment. Clinics 73, e557s (2018).","journal-title":"Clinics"},{"key":"1552_CR7","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/s00066-021-01752-x","volume":"197","author":"M Guckenberger","year":"2021","unstructured":"Guckenberger, M. Systemic effects of local radiotherapy: first clinical evidence. Strahlentherapie und Onkol. 197, 458\u2013460 (2021).","journal-title":"Strahlentherapie und Onkol."},{"key":"1552_CR8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.canlet.2015.02.007","volume":"368","author":"SM Cand\u00e9ias","year":"2015","unstructured":"Cand\u00e9ias, S. M. & Testard, I. The many interactions between the innate immune system and the response to radiation. Cancer Lett. 368, 173\u2013178 (2015).","journal-title":"Cancer Lett."},{"key":"1552_CR9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.canlet.2013.08.024","volume":"356","author":"K Lumniczky","year":"2015","unstructured":"Lumniczky, K. & S\u00e1fr\u00e1ny, G. The impact of radiation therapy on the antitumor immunity: Local effects and systemic consequences. Cancer Lett. 356, 114\u2013125 (2015).","journal-title":"Cancer Lett."},{"key":"1552_CR10","doi-asserted-by":"publisher","first-page":"661","DOI":"10.21037\/tlcr.2017.09.12","volume":"6","author":"D De Ruysscher","year":"2017","unstructured":"De Ruysscher, D. et al. Blood-based biomarkers for precision medicine in lung cancer: Precision radiation therapy. Transl. Lung Cancer Res. 6, 661\u2013669 (2017).","journal-title":"Transl. Lung Cancer Res."},{"key":"1552_CR11","doi-asserted-by":"publisher","unstructured":"Ajdari, A. et al. Toward Personalized Radiation Therapy of Liver Metastasis: Importance of Serial Blood Biomarkers. JCO Clin. Cancer Informatics 315\u2013325, https:\/\/doi.org\/10.1200\/cci.20.00118 (2021).","DOI":"10.1200\/cci.20.00118"},{"key":"1552_CR12","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1097\/JTO.0b013e3182152ba6","volume":"6","author":"XW Cai","year":"2011","unstructured":"Cai, X. W. et al. Baseline plasma proteomic analysis to identify biomarkers that predict radiation-induced lung toxicity in patients receiving radiation for non-small cell lung cancer. J. Thorac. Oncol. 6, 1073\u20131078 (2011).","journal-title":"J. Thorac. Oncol."},{"key":"1552_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers17061010","volume":"17","author":"ED Zebene","year":"2025","unstructured":"Zebene, E. D. et al. Serum-based proteomic approach to identify clinical biomarkers of radiation exposure. Cancers 17, 1\u201321 (2025).","journal-title":"Cancers"},{"key":"1552_CR14","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.ijrobp.2015.03.040","volume":"92","author":"P Widlak","year":"2015","unstructured":"Widlak, P. et al. Serum proteome signature of radiation response: upregulation of inflammation-related factors and downregulation of apolipoproteins and coagulation factors in cancer patients treated with radiation therapy\u2014a pilot study. Int. J. Radiat. Oncol. Biol. Phys. 92, 1108\u20131115 (2015).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1552_CR15","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.ijrobp.2010.01.038","volume":"77","author":"XW Cai","year":"2010","unstructured":"Cai, X. W. et al. Plasma proteomic analysis may identify new markers for radiation-induced lung toxicity in patients with non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 77, 867\u2013876 (2010).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1552_CR16","doi-asserted-by":"crossref","unstructured":"Gkikoudi, A. et al. Molecular biomarkers for predicting cancer patient radiosensitivity and radiotoxicity in clinical practice. Appl. Sci. 13, (2023).","DOI":"10.3390\/app132312564"},{"key":"1552_CR17","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.3390\/cancers16101942","volume":"16","author":"CW Bleaney","year":"2024","unstructured":"Bleaney, C. W. et al. Clinical biomarkers of tumour radiosensitivity and predicting benefit from radiotherapy: a systematic review. Cancers 16, 1942 (2024).","journal-title":"Cancers"},{"key":"1552_CR18","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1269\/jrr.11019","volume":"52","author":"P Wid\u0141ak","year":"2011","unstructured":"Wid\u0141ak, P. et al. Radiation-related changes in serum proteome profiles detected by mass spectrometry in blood of patients treated with radiotherapy due to larynx cancer. J. Radiat. Res. 52, 575\u2013581 (2011).","journal-title":"J. Radiat. Res."},{"key":"1552_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-11-299","volume":"11","author":"P Wid\u0142ak","year":"2013","unstructured":"Wid\u0142ak, P. et al. Radiotherapy-related changes in serum proteome patterns of head and neck cancer patients; the effect of low and medium doses of radiation delivered to large volumes of normal tissue. J. Transl. Med. 11, 1\u20139 (2013).","journal-title":"J. Transl. Med."},{"key":"1552_CR20","doi-asserted-by":"crossref","unstructured":"Truscott, T. G. & Sinclair, R. S. Advances in Experimental Medicine and Biology. International Journal of Radiation Biology vol. 44 (1983).","DOI":"10.1080\/09553008314551361"},{"key":"1552_CR21","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/nbt1235","volume":"24","author":"N Rifai","year":"2006","unstructured":"Rifai, N., Gillette, M. A. & Carr, S. A. Protein biomarker discovery and validation: The long and uncertain path to clinical utility. Nat. Biotechnol. 24, 971\u2013983 (2006).","journal-title":"Nat. Biotechnol."},{"key":"1552_CR22","doi-asserted-by":"publisher","first-page":"5576","DOI":"10.1158\/1078-0432.CCR-09-0245","volume":"15","author":"E Christensen","year":"2009","unstructured":"Christensen, E. et al. Longitudinal cytokine expression during IMRT for prostate cancer and acute treatment toxicity. Clin. Cancer Res. 15, 5576\u20135583 (2009).","journal-title":"Clin. Cancer Res."},{"key":"1552_CR23","doi-asserted-by":"publisher","first-page":"e2898","DOI":"10.1371\/journal.pone.0002898","volume":"3","author":"CE R\u00fcbe","year":"2008","unstructured":"R\u00fcbe, C. E. et al. Cytokine plasma levels: reliable predictors for radiation pneumonitis? PLoS One 3, e2898 (2008).","journal-title":"PLoS One"},{"key":"1552_CR24","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.ebiom.2015.06.013","volume":"2","author":"MJ Walker","year":"2015","unstructured":"Walker, M. J. et al. Discovery and validation of predictive biomarkers of survival for non-small cell lung cancer patients undergoing radical radiotherapy: two proteins with predictive value. EBioMedicine 2, 841\u2013850 (2015).","journal-title":"EBioMedicine"},{"key":"1552_CR25","unstructured":"Cohen, I. R., Lajtha, A., Lambris, J. D. & Paoletti, R. Radiation Proteomics, Chapter 4, Serum and Plasma Proteomics and Its Possible Use as Detector and Predictor of Radiation Diseases. Proteomics vol. 13 (2013)."},{"key":"1552_CR26","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.biomaterials.2018.10.011","volume":"188","author":"M Hadjidemetriou","year":"2019","unstructured":"Hadjidemetriou, M., Al-ahmady, Z., Buggio, M., Swift, J. & Kostarelos, K. A novel scavenging tool for cancer biomarker discovery based on the blood-circulating nanoparticle protein corona. Biomaterials 188, 118\u2013129 (2019).","journal-title":"Biomaterials"},{"key":"1552_CR27","doi-asserted-by":"publisher","first-page":"e1803335","DOI":"10.1002\/adma.201803335","volume":"31","author":"M Hadjidemetriou","year":"2019","unstructured":"Hadjidemetriou, M. et al. The human in vivo biomolecule corona onto pegylated liposomes: a proof-of-concept clinical study. Adv. Mater. 31, e1803335 (2019).","journal-title":"Adv. Mater."},{"key":"1552_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2020.100901","volume":"34","author":"M Hadjidemetriou","year":"2020","unstructured":"Hadjidemetriou, M. et al. Nano-scavengers for blood biomarker discovery in ovarian carcinoma. Nano Today 34, 100901 (2020).","journal-title":"Nano Today"},{"key":"1552_CR29","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41578-024-00658-1","volume":"9","author":"M Hadjidemetriou","year":"2024","unstructured":"Hadjidemetriou, M., Mahmoudi, M. & Kostarelos, K. In vivo biomolecule corona and the transformation of a foe into an ally for nanomedicine. Nat. Rev. Mater.2024 94 9, 219\u2013222 (2024).","journal-title":"Nat. Rev. Mater."},{"key":"1552_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58252-0","volume":"16","author":"X Liu","year":"2025","unstructured":"Liu, X. et al. Plasma-to-tumour tissue integrated proteomics using nano-omics for biomarker discovery in glioblastoma. Nat. Commun. 16, 3412 (2025).","journal-title":"Nat. Commun."},{"key":"1552_CR31","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1074\/mcp.M500230-MCP200","volume":"5","author":"JC Silva","year":"2006","unstructured":"Silva, J. C., Gorenstein, M. V., Li, G. Z., Vissers, J. P. C. & Geromanos, S. J. Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition. Mol. Cell. Proteom. 5, 144\u2013156 (2006).","journal-title":"Mol. Cell. Proteom."},{"key":"1552_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15252\/msb.20178124","volume":"14","author":"R Argelaguet","year":"2018","unstructured":"Argelaguet, R. et al. Multi-omics factor analysis\u2014a framework for unsupervised integration of multi-omics data sets. Mol. Syst. Biol. 14, 1\u201313 (2018).","journal-title":"Mol. Syst. Biol."},{"key":"1552_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1540-4781.2010.01136.x","volume":"94","author":"H Byrnes","year":"2010","unstructured":"Byrnes, H., Maxim, H. H. & Norris, J. M. Identifying temporal and spatial patterns of variation from multi_modal data using MEFISTO. Mod. Lang. J. 94, 1\u2013202 (2010).","journal-title":"Mod. Lang. J."},{"key":"1552_CR34","doi-asserted-by":"publisher","first-page":"10240","DOI":"10.1039\/D0NR02788J","volume":"12","author":"L Papafilippou","year":"2020","unstructured":"Papafilippou, L., Claxton, A., Dark, P., Kostarelos, K. & Hadjidemetriou, M. Protein corona fingerprinting to differentiate sepsis from non-infectious systemic inflammation. Nanoscale 12, 10240\u201310253 (2020).","journal-title":"Nanoscale"},{"key":"1552_CR35","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s41571-022-00645-x","volume":"19","author":"L Gardner","year":"2022","unstructured":"Gardner, L., Kostarelos, K., Mallick, P., Dive, C. & Hadjidemetriou, M. Nano-omics: nanotechnology-based multidimensional harvesting of the blood-circulating cancerome. Nat. Rev. Clin. Oncol. 19, 551\u2013561 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1552_CR36","doi-asserted-by":"publisher","first-page":"8142","DOI":"10.1021\/acsnano.5b03300","volume":"9","author":"M Hadjidemetriou","year":"2015","unstructured":"Hadjidemetriou, M. et al. In vivo biomolecule corona around blood-circulating, clinically used and antibody-targeted lipid bilayer nanoscale vesicles. ACS Nano 9, 8142\u20138156 (2015).","journal-title":"ACS Nano"},{"key":"1552_CR37","doi-asserted-by":"publisher","first-page":"6948","DOI":"10.1039\/C5NR09158F","volume":"8","author":"M Hadjidemetriou","year":"2016","unstructured":"Hadjidemetriou, M., Al-Ahmady, Z. & Kostarelos, K. Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles. Nanoscale 8, 6948\u20136957 (2016).","journal-title":"Nanoscale"},{"key":"1552_CR38","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1021\/acs.jproteome.4c00104","volume":"23","author":"B Ward","year":"2024","unstructured":"Ward, B. et al. Deep plasma proteomics with data-independent acquisition: clinical study protocol optimization with a COVID-19 cohort. J. Proteome Res. 23, 3806\u20133822 (2024).","journal-title":"J. Proteome Res."},{"key":"1552_CR39","unstructured":"Kyle W., Joel E. Tepper, M. Radiation therapy- associated toxicity: etiology, management, and prevention. at (2021)."},{"key":"1552_CR40","first-page":"e18147","volume":"13","author":"R Chugh","year":"2021","unstructured":"Chugh, R., Bisht, Y. S., Nautiyal, V. & Jindal, R. Factors influencing the severity of acute radiation-induced skin and mucosal toxicity in head and neck cancer. Cureus 13, e18147 (2021).","journal-title":"Cureus"},{"key":"1552_CR41","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.radonc.2021.02.007","volume":"158","author":"H Wijerathne","year":"2022","unstructured":"Wijerathne, H. et al. Mechanisms of radiation-induced endothelium damage: emerging models and technologies Harshani. Radiother. Oncol. 158, 21\u201332 (2022).","journal-title":"Radiother. Oncol."},{"key":"1552_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2021.680503","volume":"12","author":"J Constanzo","year":"2021","unstructured":"Constanzo, J., Faget, J., Ursino, C., Badie, C. & Pouget, J. P. Radiation-induced immunity and toxicities: the versatility of the cGAS-STING pathway. Front. Immunol. 12, 1\u201317 (2021).","journal-title":"Front. Immunol."},{"key":"1552_CR43","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jacbts.2018.01.014","volume":"3","author":"BP Venkatesulu","year":"2018","unstructured":"Venkatesulu, B. P. et al. Radiation-induced endothelial vascular injury: a review of possible mechanisms. JACC Basic Transl. Sci. 3, 563\u2013572 (2018).","journal-title":"JACC Basic Transl. Sci."},{"key":"1552_CR44","doi-asserted-by":"publisher","first-page":"110689","DOI":"10.1016\/j.radonc.2024.110689","volume":"203","author":"A Koch","year":"2025","unstructured":"Koch, A., Reinhardt, P., Elicin, O., Aebersold, D. M. & Schanne, D. H. Predictive biomarkers of radiotherapy- related dermatitis, xerostomia, mucositis and dysphagia in head and neck cancer: a systematic review. Radiother. Oncol. 203, 110689 (2025).","journal-title":"Radiother. Oncol."},{"key":"1552_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2017.00083","volume":"7","author":"D Azria","year":"2017","unstructured":"Azria, D. et al. Data-based radiation oncology: Design of clinical trials in the toxicity biomarkers era. Front. Oncol. 7, 1\u201311 (2017).","journal-title":"Front. Oncol."},{"key":"1552_CR46","doi-asserted-by":"publisher","first-page":"20150009","DOI":"10.1259\/bjr.20150009","volume":"88","author":"AH Ree","year":"2015","unstructured":"Ree, A. H. & Redalen, K. R. Personalized radiotherapy: concepts, biomarkers and trial design. Br. J. Radiol. 88, 20150009 (2015).","journal-title":"Br. J. Radiol."},{"key":"1552_CR47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1586\/epr.12.68","volume":"10","author":"J Lacombe","year":"2013","unstructured":"Lacombe, J., Azria, D., Mange, A. & Solassol, J. Proteomic approaches to identify biomarkers predictive of radiotherapy outcomes. Expert Rev. Proteom. 10, 33\u201342 (2013).","journal-title":"Expert Rev. Proteom."},{"key":"1552_CR48","doi-asserted-by":"publisher","first-page":"100603","DOI":"10.1016\/j.adro.2020.10.016","volume":"6","author":"NJ Nasser","year":"2021","unstructured":"Nasser, N. J., Klein, J. & Agbarya, A. Markers of toxicity and response to radiation therapy in patients with prostate cancer. Adv. Radiat. Oncol. 6, 100603 (2021).","journal-title":"Adv. Radiat. Oncol."},{"key":"1552_CR49","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S1043-4666(03)00185-6","volume":"23","author":"CJ Kovacs","year":"2003","unstructured":"Kovacs, C. J. et al. Cytokine profiles in patients receiving wide-field + prostate boost radiotherapy (xRT) for adenocarcinoma of the prostate. Cytokine 23, 151\u2013163 (2003).","journal-title":"Cytokine"},{"key":"1552_CR50","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1080\/00365520903039952","volume":"44","author":"A Hille","year":"2009","unstructured":"Hille, A. et al. Faecal calprotectin and lactoferrin values during irradiation of prostate cancer correlate with chronic radiation proctitis: results of a prospective study. Scand. J. Gastroenterol. 44, 939\u2013946 (2009).","journal-title":"Scand. J. Gastroenterol."},{"key":"1552_CR51","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3109\/0284186X.2011.584557","volume":"50","author":"C Onal","year":"2011","unstructured":"Onal, C. et al. Plasma citrulline levels predict intestinal toxicity in patients treated with pelvic radiotherapy. Acta Oncol. 50, 1167\u20131174 (2011).","journal-title":"Acta Oncol."},{"key":"1552_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2020.00628","volume":"10","author":"J Meehan","year":"2020","unstructured":"Meehan, J. et al. Precision medicine and the role of biomarkers of radiotherapy response in breast cancer. Front. Oncol. 10, 1\u201316 (2020).","journal-title":"Front. Oncol."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01552-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01552-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01552-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:03:34Z","timestamp":1779840214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01552-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1552"],"URL":"https:\/\/doi.org\/10.1038\/s43856-026-01552-3","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"14 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"308"}}